Open AccessColonization and Antibiotic Resistance Profiling of Methicillin Resistant Staphylococcus Aureus (Mrsa) in Patients from Tertiary
Author(s) -
Madiha Khan,
Wafa Komal,
Muhammad Saleem,
Naveed Ahmad,
Zara Rafaque,
Saba Kabir,
Abdul Rehman
Publication year - 2020
Publication title -
the journal of microbiology and molecular genetics
Language(s) - English
Resource type - Journals
eISSN - 2788-8312
pISSN - 2707-6431
DOI - 10.52700/jmmg.v1i3.11
Subject(s) - linezolid , clindamycin , medicine , methicillin resistant staphylococcus aureus , staphylococcus aureus , teicoplanin , vancomycin , amikacin , cefoxitin , gentamicin , microbiology and biotechnology , daptomycin , fusidic acid , antibiotic resistance , antibiotics , tigecycline , biology , bacteria , genetics
The methicillin resistant Staphylococcus aureus (MRSA) is affecting the economy worldwide contributing to the increased morbidity and treatment costs. The present cross sectional study was conducted to determine the association of MRSA with kidney and liver patients from Tertiary Care Hospital in Lahore, Pakistan and its antibacterialresistance patterns. The study was conducted for the period of one year; from April 2019 to April 2020. A total of 1984 different samples were obtained and examined for bacterial cultures using standard procedures. From total samples, 51.05% were collected from male and the rest 48.95% were collected from females including different age groups. Samples were inoculated on different culture media for isolation of S. aureus and susceptibility testing. A total of 253/1984 clinical samples exhibited S. aureus characteristics while 39 of 253 S. aureus (15.41%) were identified as MRSA. MRSA strains were found highly resistant to Amikacin (AK), Cefoxitin (FOX),Clindamycin (DA), Fusidic acid (FD), Gentamicin (CN) and Tobramycin (TOB) while highest sensitivity was noted against Vancomycin (100%) and Linezolid (100%). The presence of MRSA and multidrug resistance pose serious therapeutic burden to critically ill patients. A systematic and concerted effort is essential to identify high-risk patients rapidly and to reduce the burden of antimicrobial resistance.